PACAP type I receptor transactivation is essential for IGF‐1 receptor signalling and antiapoptotic activity in neurons
Nicolas Delcourt(Inserm), Philippe Marin(Centre National de la Recherche Scientifique), Benjamin Chanrion(Centre National de la Recherche Scientifique), Joël Bockaert(Centre National de la Recherche Scientifique), Patrick Jouin(Centre National de la Recherche Scientifique), Éric Thouvenot(Centre National de la Recherche Scientifique)
Cited by 68
Related Papers
Conversion from clinically isolated syndrome to multiple sclerosis: A large multicentre study
|Multiple Sclerosis Journal|2015|298
Treatment of MOG-IgG-associated disorder with rituximab: An international study of 121 patients
|Multiple Sclerosis and Related Disorders|2020|179
GPCR-jacking: from a new route in RTK signalling to a new concept in GPCR activation
|Trends in Pharmacological Sciences|2007|173
Glutamate-dependent phosphorylation of elongation factor-2 and inhibition of protein synthesis in neurons.
|PubMed|1997|167
5‐HT6 receptor recruitment of mTOR as a mechanism for perturbed cognition in schizophrenia
|EMBO Molecular Medicine|2012|164